Daclatasvir: A Review of Its Use in Adult Patients with Chronic Hepatitis C Virus Infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Daclatasvir: A Review of Its Use in Adult Patients with Chronic Hepatitis C Virus Infection
Authors
Keywords
Dabigatran Etexilate, Telaprevir, Sofosbuvir, Boceprevir, Virological Breakthrough
Journal
DRUGS
Volume 75, Issue 5, Pages 515-524
Publisher
Springer Nature
Online
2015-02-26
DOI
10.1007/s40265-015-0362-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- Different Interaction Profiles of Direct-Acting Anti-Hepatitis C Virus Agents with Human Organic Anion Transporting Polypeptides
- (2014) Tomomi Furihata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity
- (2014) Chunfu Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Virologic escape in HCV genotype 1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b
- (2014) Fiona McPhee et al. ANTIVIRAL THERAPY
- A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection
- (2014) Fumitaka Suzuki et al. ANTIVIRAL THERAPY
- Daclatasvir combined with peginterferon alfa-2a and ribavirin in Japanese patients infected with hepatitis C genotype 1
- (2014) Namiki Izumi et al. ANTIVIRAL THERAPY
- Global distribution and prevalence of hepatitis C virus genotypes
- (2014) Jane P. Messina et al. HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2014
- (2014) JOURNAL OF HEPATOLOGY
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection
- (2014) E. Druyts et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
- (2013) Marc Bifano et al. ANTIVIRAL THERAPY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
- (2013) J. Guedj et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir
- (2012) Lenore A. Pelosi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 1207 TRIPLE THERAPY WITH DACLATASVIR (DCV; BMS-790052), PEGINTERFERON ALFA-2A AND RIBAVIRIN IN HCV-INFECTED PRIOR NULL AND PARTIAL RESPONDERS: 12-WEEK RESULTS OF PHASE 2B COMMAND-2 TRIAL
- (2012) V. Ratziu et al. JOURNAL OF HEPATOLOGY
- Distribution of hepatitis C virus genotypes in a diverse US integrated health care population
- (2012) M. Michele Manos et al. JOURNAL OF MEDICAL VIROLOGY
- Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
- (2012) Stanislas Pol et al. LANCET INFECTIOUS DISEASES
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- An overview of HCV molecular biology, replication and immune responses
- (2011) Usman A Ashfaq et al. Virology Journal
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
- (2010) R. A. Fridell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started